Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516890 | SCV000615517 | benign | not specified | 2017-01-17 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726837 | SCV000703524 | uncertain significance | not provided | 2016-12-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726837 | SCV000730119 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080534 | SCV000758026 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317864 | SCV000850466 | likely benign | Inborn genetic diseases | 2017-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000726837 | SCV001962570 | likely benign | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing |